Eli Lilly's weight-loss drug retatrutide passes obesity trial
Eli Lilly on Thursday said its next-generation drug passed a crucial late-stage trial in obese patients, achieving significant weight loss…
Spdr S&P Pharmaceuticals Etf
Novartis, Amgen and Eli Lilly's Lp(a) Drugs Aim to Prevent Heart Attacks
Pharma believes it has found the next frontier in heart attack prevention. Novartis, amgen and Eli Lilly are among drugmakers…
Trump prepares pharmaceutical tariffs of up to 100%
The Trump administration on Thursday imposed new tariffs on brand-name drugs from pharmaceutical companies that have not reached agreements with…
Novo says Wegovy pill outperforms Lilly's oral GLP-1
Wegovy semaglutide tablets. Michael Siluk | Universal Image Group | fake images The Wegovy pill showed more pronounced weight loss…
Eli Lilly reaches agreement to bring AI-developed medicines to the global market
A drone view shows the Eli Lilly logo at the company's office in San Diego, California, on November 21, 2025.…
AstraZeneca shares rise after surprise lung disease trial win
AstraZenecaShares rose more than 3% after Britain's most valuable company said its experimental drug for lung diseases met its target…
Pfizer Lyme Disease Vaccine Fails in Trial, Company Will Seek FDA Approval
Thomas Fuller | Nurfoto | fake images Pfizer on Monday said it will seek regulatory approval for a Lyme disease…
FDA approves high-dose version of Novo Nordisk's anti-obesity drug Wegovy
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, on February…
J&J's Icotyde Psoriasis Pill Rivals Tremfya Skyrizi IL-23 Injections
Signs outside the Johnson & Johnson offices in Irvine, California, U.S., on Friday, October 10, 2025. Kyle Grillot Bloomberg |…
Why Novo Nordisk's expansion in Ireland is key to fighting Eli Lilly
Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its production capabilities to…